Consensus vs Paperguide
Side-by-side comparison of features, pricing, ratings, and alternatives.
Consensus is an AI research tool built specifically for academic and clinical literature, searching and analyzing over 250 million research papers, including licensed full-text content from leading publishers. Its Deep Search feature automates literature reviews by building a search strategy, expanding key terms, identifying conflicting arguments, and exploring the citation graph, turning what the company describes as days of manual review into minutes. A Medical mode narrows results to roughly 50,000 clinical guidelines and 8 million articles from top medical journals for faster clinical answers, while the Consensus Meter gives a visual read on how much existing evidence agrees or disagrees on a yes/no research question. Over 170 university libraries partner with Consensus, and the company says more than 10 million researchers, students, and clinicians use it; pricing runs free up to a $45/month Deep plan for frequent literature reviews.
Paperguide is an AI-native platform for scientific research workflows and evidence synthesis. It combines AI search across 200M+ papers, reference management, research agents, systematic review tools with PRISMA reporting, and citation-grounded AI writing in one workspace. It is designed for researchers and teams who need findable, traceable, and auditable literature evidence.
No specific pricing is listed; the page refers to adding seats for teams but no plan names or prices appear.
- Draws on a genuinely large, licensed corpus of peer-reviewed literature
- Deep Search can compress a manual literature review into minutes
- Consensus Meter gives a fast visual read on scientific agreement
- Free tier available before committing to a paid plan
- All-in-one workflow: search, organize, synthesize, review, and write in one place.
- Citation-grounded outputs with statement-level traceability.
- Built-in support for rigorous systematic reviews and PRISMA reporting.
- AI-assisted screening and extraction that keeps human accountability.
- Deep review usage is capped even on the Pro plan (15/month)
- Medical mode and clinical answers are meant to support, not replace, professional judgment
- Heaviest use cases requiring frequent literature reviews need the $45/month Deep plan
- Pricing and free tier are not disclosed on the page.
- Security/compliance certifications like GDPR, SOC 2, and ISO 27001 are listed as coming soon.
- AI outputs still require human verification, especially for formal systematic reviews.
- May have a learning curve for teams not familiar with systematic review workflows.
More alternatives & similar tools
Alternatives to Consensus
View all →
A free AI-powered search engine that helps researchers discover and understand scientific papers.
AI research assistant that searches, summarizes, and extracts data from millions of papers.
A visual literature discovery tool for mapping connections between academic papers.
Alternatives to Paperguide
View all →
An AI-powered research productivity tool that summarizes papers, extracts key information, and helps researchers engage with content.
The Verdict
AI-generated from listing dataPaperguide offers a comprehensive, AI‑driven end‑to‑end systematic‑review workflow with strong citation traceability, while Consensus provides a broader, faster literature‑search and summarization tool with a free tier but limited deep‑review capacity.
Key differences
- •Paperguide includes built‑in PRISMA‑aligned systematic‑review workflows and dual‑review conflict resolution; Consensus focuses on rapid search/summarization without formal review structures.
- •Paperguide’s AI writer supports 1,000+ citation styles and generates cited tables; Consensus offers only summary generation and a visual “Consensus Meter.”
- •Paperguide provides team collaboration spaces, role‑based access, and imports from Zotero/Mendeley; Consensus mentions institutional library partnerships but no explicit collaboration features.
- •Paperguide’s pricing details are undisclosed and security certifications are “coming soon”; Consensus has a freemium model with a paid $45/month Deep plan and known usage caps.
- •Paperguide claims traceability to exact source sentences for every claim; Consensus does not specify claim‑level traceability.
Pricing & value
Consensus offers a clear freemium tier and a $45/month Deep plan; Paperguide’s pricing is undisclosed.
Ease of use / learning curve
Consensus provides quick search and summary; Paperguide includes complex systematic‑review workflows that may require training.
Features & depth
Paperguide delivers full research lifecycle: AI search, reference manager, PRISMA workflow, dual review, citation‑grounded writing.
Integrations & ecosystem
Paperguide imports from Zotero, Mendeley, DOI links; Consensus only mentions institutional library access, no explicit import tools.
Collaboration
Paperguide offers shared workspaces, roles, and team seats; Consensus lacks described collaboration features.
Scalability
Consensus is cloud SaaS with known usage caps; Paperguide’s scalability unclear due to missing pricing and compliance info.
Security & privacy
Consensus provides no security details but is operational; Paperguide lists certifications as “coming soon,” indicating less mature compliance.
Choose Consensus if…
Individual researchers or clinicians who want fast literature search and summary without full systematic‑review tooling.
Choose Paperguide if…
Research teams needing formal systematic‑review processes, PRISMA compliance, and collaborative reference management.
Common questions
What are the pricing models?
Paperguide is freemium but does not disclose seat or plan prices; Consensus offers a freemium tier and a $45/month Deep plan.
Does either tool support formal systematic‑review workflows?
Paperguide includes dual‑review, conflict resolution, PRISMA diagram, and AI‑assisted screening; Consensus does not provide systematic‑review features.
How does citation traceability work?
Paperguide traces each claim to the exact sentence in the source paper; Consensus does not specify claim‑level traceability.